Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-7 of 7
Keywords: labetalol
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
An Analysis of the Blood Pressure Response to Labetalol in Hypertensive Patients
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1981) 61 (s7): 449s–452s.
Published: 01 December 1981
...J. J. McNeil; A. E. Anderson; W. J. Louis 1. Blood pressure measurements were made in hypertensive subjects after single intravenous and oral doses of labetalol and subsequently during chronic administration. 2. Oral therapy can be as effective as intravenous therapy in achieving acute blood...
Articles
Effects of Combined α- and β -Receptor Blockade on Peripheral Circulation in Essential Hypertension
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1981) 61 (s7): 429s–432s.
Published: 01 December 1981
...I. Heck; G. Trübestein; K. O. Stumpe 1. Six weeks' treatment with labetalol (600 mg/day) significantly reduced systolic and diastolic blood pressures in 24 patients with essential hypertension. There was a small but not significant decrease in heart rate. 2. After 6 weeks of therapy mean digital...
Articles
Effect of Increasing Doses of Labetalol on Blood Pressure, Plasma Renin Activity and Aldosterone in Hypertensive Patients
Available to Purchase
Journal:
Clinical Science
Clin Sci (Lond) (1979) 57 (s5): 401s–404s.
Published: 01 December 1979
...A. Salvetti; R. Pedrinelli; P. Sassano; F. Arzilli 1. Four different doses of labetalol (150, 300, 600 and 900 mg/day) were given for 1 week to each of four groups of patients with essential hypertension (six patients for each group). 2. Labetalol decreased mean blood pressure and heart rate...
Articles
Effects of Labetalol on Systemic and Pulmonary Haemodynamics at Rest and during Exercise in Hypertensive Patients
Available to Purchase
Journal:
Clinical Science
Clin Sci Mol Med (1978) 55 (s4): 279s–281s.
Published: 01 December 1978
...R. Fagard; A. Amery; T. Reybrouck; P. Lijnen; L. Billiet 1. Labetalol was administered to 18 hypertensive patients for an average duration of 2·44 weeks, with an average final daily dose of 1·65 g. 2. Labetalol decreased resting heart rate by 16% and maximal exercise heart rate by 21...
Articles
Combined α- and β-Adrenoreceptor Blockade in Hypertension: A Controlled Trial of Labetalol (AH 5158) Compared with Propranolol and Placebo
Available to Purchase
Journal:
Clinical Science
Clin Sci Mol Med (1976) 51 (s3): 501s–563s.
Published: 01 December 1976
...D. Pugsley; B. Armstrong; M. Nassim; L. J. Beilin 1. Labetalol (AH 5158) is a new drug which has both α- and β-adrenoreceptor antagonist activity. Labetalol has been compared with propranolol and placebo for the treatment of mild to moderate hypertension (150/100 to 189/114 mmHg), in a double-blind...
Articles
The Anti-Hypertensive Efficacy of Combined α- and β-Adrenoreceptor Blockade with Phentolamine—Oxprenolol or with Labetalol (AH 5158)
Available to Purchase
Journal:
Clinical Science
Clin Sci Mol Med (1976) 51 (s3): 505s–507s.
Published: 01 December 1976
...-exercise blood pressures. Small reductions were seen only with sustained phentolamine administration. 4. The combined effect of the two drugs appeared to be additive only at the lower doses of oxprenolol. 5. Labetalol produced significantly greater reductions in supine and standing blood pressure than...
Articles
Effects of Intravenous Labetalol on Blood Pressure, Angiotensin II and Aldosterone in Hypertension: Comparison with Propranolol
Available to Purchase
Journal:
Clinical Science
Clin Sci Mol Med (1976) 51 (s3): 497s–499s.
Published: 01 December 1976
...E. A. Rosei; P. M. Trust; J. J. Brown; R. Fraser; A. F. Lever; J. J. Morton; J. I. S. Robertson 1. Labetalol, a compound with both α- and β-adrenoreceptor-blocking actions, was given intravenously (1·5–2·0 mg/kg) in twenty recumbent hypertensive patients. 2. There was a rapid reduction in systolic...